A recent trade mission to Israel led by Philadelphia Mayor Michael A. Nutter has led to a new research agreement between The Children's Hospital of Philadelphia (CHOP), Drexel University, and the Hebrew University of Jerusalem. The partnership will be focused on pediatric translational research and moving investigations from the bench to the bedside.
Investigators at Children's Hospital work tirelessly to uncover the inner workings of biological systems and the causes of diseases. But making discoveries is only part of the challenge; the next set of challenges often lies with taking the new knowledge from discoveries and working with outside partners to bring promising new therapeutics and treatments to patients.
The Children's Hospital of Philadelphia and Pfizer, Inc., the world's largest research-based pharmaceutical company, are joining forces with the goal of translating biomedical discoveries into novel treatments. Children's Hospital is set join the Centers for Therapeutic Innovation (CTI) network, a novel collaboration model built by Pfizer that brings academic researchers together with Pfizer scientists to expedite the pace of innovation.
